List of insiders holdings for Immix Biopharma Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Hsu Jason Director | 2023-12-12 18:25:25 | 813,000 3,965,913 | 4,778,913 | Form 4 |
| Ng Carey Director | 2023-09-15 18:27:44 | 10000 1,025,221 | 1,035,221 | Form 4 |
| Torchilin Vladimir P Scientific Co-Founder | 2021-12-20 16:15:22 | 905,200 0 | 905,200 | Form 4 |
| Senn Sean Under 10% owner | 2022-07-22 16:12:46 | 899,800 0 | 899,800 | Form 4/A |
| Rachman Ilya M CEO and Chairman | 2023-11-09 19:54:21 | 293,000 0 | 293,000 | Form 4/A |
| Morris Gabriel S CFO | 2023-11-09 19:57:06 | 293,000 0 | 293,000 | Form 4/A |
| Chudnovsky Yekaterina Director 10% Owner | 2023-08-23 16:28:40 | 36,670 0 | 36,670 | Form 4 |
| Marquet Magda Director | 2023-09-08 17:46:34 | 0 20,000 | 20,000 | Form 4 |
| BUCHAN MELISSA JANE Director | 2023-09-11 17:18:05 | 20,000 0 | 20,000 | Form 4 |
| Ross Graham CMO & Head of Clinical Dev. | 2021-12-15 21:01:13 | 15,000 0 | 15,000 | Form 3 |
| Adams Helen C. Director | 2023-09-14 17:20:59 | 13,000 0 | 13,000 | Form 4 |